Radiosensitization by gold nanoparticles: Will they ever make it to the clinic?
Cui L, Her S, Borst GR, Bristow RG, Jaffray DA, Allen C.
Radiother Oncol. 2017 Sep;124(3):344-356. doi: 10.1016/j.radonc.2017.07.007. Epub 2017 Aug 4.
Recent developments in radiosensitization.
Linam J, Yang LX.
Anticancer Res. 2015 May;35(5):2479-85.
Progression in low-intensity ultrasound-induced tumor radiosensitization.
Xu H, Liu Z, Du M, Chen Z.
Cancer Med. 2024 Jul;13(13):e7332. doi: 10.1002/cam4.7332.
Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.
Farhood B, Goradel NH, Mortezaee K, Khanlarkhani N, Salehi E, Nashtaei MS, Mirtavoos-Mahyari H, Motevaseli E, Shabeeb D, Musa AE, Najafi M.
Clin Transl Oncol. 2019 Mar;21(3):268-279. doi: 10.1007/s12094-018-1934-0. Epub 2018 Aug 22.
Role of metabolism in cancer cell radioresistance and radiosensitization methods.
Tang L, Wei F, Wu Y, He Y, Shi L, Xiong F, Gong Z, Guo C, Li X, Deng H, Cao K, Zhou M, Xiang B, Li X, Li Y, Li G, Xiong W, Zeng Z.
J Exp Clin Cancer Res. 2018 Apr 23;37(1):87. doi: 10.1186/s13046-018-0758-7.
Radiosensitization in head and neck cancer: do we have an alternative to platins? Role of taxanes.
Joseph B, Vishwanath L, Venugopal BK.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Mar;117(3):324-8. doi: 10.1016/j.oooo.2013.10.006. Epub 2013 Oct 17.
Radioprotection and radiosensitization by curcumin.
Jagetia GC.
Adv Exp Med Biol. 2007;595:301-20. doi: 10.1007/978-0-387-46401-5_13.
Molecular targets and mechanisms of radiosensitization using DNA damage response pathways.
Raleigh DR, Haas-Kogan DA.
Future Oncol. 2013 Feb;9(2):219-33. doi: 10.2217/fon.12.185.
Histone deacetylation as a target for radiosensitization.
Cerna D, Camphausen K, Tofilon PJ.
Curr Top Dev Biol. 2006;73:173-204. doi: 10.1016/S0070-2153(05)73006-4.
Radiosensitization effect of Huaier on breast cancer cells.
Ding X, Yang Q, Kong X, Haffty BG, Gao S, Moran MS.
Oncol Rep. 2016 May;35(5):2843-50. doi: 10.3892/or.2016.4630. Epub 2016 Feb 23.
